Stanley R. Howell

566 total citations
20 papers, 452 citations indexed

About

Stanley R. Howell is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Stanley R. Howell has authored 20 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Stanley R. Howell's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Retinoids in leukemia and cellular processes (5 papers). Stanley R. Howell is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Retinoids in leukemia and cellular processes (5 papers). Stanley R. Howell collaborates with scholars based in United States, France and Canada. Stanley R. Howell's co-authors include JoAnn Scatina, Samuel F. Sisenwine, G. E. M. Husbands, Curtis D. Klaassen, Michael A. Shirley, E H Ulm, David Hicks, G A Hazelton, Zoltán Gregus and Catherine A. White and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Biochemistry.

In The Last Decade

Stanley R. Howell

20 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley R. Howell United States 11 151 118 78 61 53 20 452
Ram Chandra Gupta India 13 160 1.1× 104 0.9× 134 1.7× 31 0.5× 38 0.7× 41 565
Toshiaki Amamoto Japan 14 162 1.1× 90 0.8× 135 1.7× 47 0.8× 44 0.8× 21 578
Alvin N. Kotake United States 16 132 0.9× 259 2.2× 84 1.1× 48 0.8× 26 0.5× 27 663
Melinda K. Shelby United States 6 134 0.9× 142 1.2× 64 0.8× 29 0.5× 23 0.4× 7 457
Dwight D. Stiff United States 13 158 1.0× 121 1.0× 51 0.7× 21 0.3× 55 1.0× 18 444
Barbara W. LeDuc United States 13 106 0.7× 132 1.1× 100 1.3× 36 0.6× 13 0.2× 28 455
M. Volz Germany 10 150 1.0× 49 0.4× 48 0.6× 36 0.6× 46 0.9× 24 422
J Pachecka Poland 15 174 1.2× 94 0.8× 44 0.6× 14 0.2× 38 0.7× 57 556
Satoshi Toki Japan 15 186 1.2× 224 1.9× 88 1.1× 72 1.2× 148 2.8× 55 697
D. R. FELLER United States 13 242 1.6× 135 1.1× 69 0.9× 68 1.1× 21 0.4× 47 533

Countries citing papers authored by Stanley R. Howell

Since Specialization
Citations

This map shows the geographic impact of Stanley R. Howell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley R. Howell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley R. Howell more than expected).

Fields of papers citing papers by Stanley R. Howell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley R. Howell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley R. Howell. The network helps show where Stanley R. Howell may publish in the future.

Co-authorship network of co-authors of Stanley R. Howell

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley R. Howell. A scholar is included among the top collaborators of Stanley R. Howell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley R. Howell. Stanley R. Howell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Zhe-ming, Ruediger Nave, Hao Feng, et al.. (2007). Comparative In Vitro Metabolism of 14C-Ciclesonide in Hepatocytes From the Mouse, Rat, Rabbit, Dog, and Human. American Journal of Therapeutics. 14(3). 280–290. 6 indexed citations
2.
Guo, Zuyu, Zhe-ming Gu, Stanley R. Howell, et al.. (2006). Ciclesonide Disposition and Metabolism: Pharmacokinetics, Metabolism, and Excretion in the Mouse, Rat, Rabbit, and Dog. American Journal of Therapeutics. 13(6). 490–501. 8 indexed citations
3.
Martin, Nancy, et al.. (2004). No Clinically Relevant CYP3A Induction with the Dual Angiotensin‐Converting Enzyme/Neutral Endopeptidase Inhibitor, M100240. The Journal of Clinical Pharmacology. 44(4). 379–387. 2 indexed citations
4.
Kim, Jungwook, Stanley R. Howell, Xinyi Huang, & Frank M. Raushel. (2002). Structural Defects within the Carbamate Tunnel of Carbamoyl Phosphate Synthetase. Biochemistry. 41(42). 12575–12581. 9 indexed citations
5.
Howell, Stanley R., et al.. (2001). Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors.. PubMed. 29(7). 990–8. 27 indexed citations
6.
Howell, Stanley R., Michael A. Shirley, & E H Ulm. (1998). Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.. PubMed. 26(3). 234–9. 39 indexed citations
7.
Shirley, Michael A., Pat Wheelan, Stanley R. Howell, & Robert C. Murphy. (1997). Oxidative metabolism of a rexinoid and rapid phase II metabolite identification by mass spectrometry.. PubMed. 25(10). 1144–9. 12 indexed citations
8.
Allegretto, Elizabeth A., Nirupama K. Shevde, Aihua Zou, et al.. (1996). Retinoid X receptor acts as a hormone receptor in vivo to induce a key metabolic enzyme for 1,25-dihydroxyvitamin D3.. Journal of Biological Chemistry. 271(11). 6562–6562. 3 indexed citations
9.
Allegretto, Elizabeth A., Nirupama K. Shevde, Aihua Zou, et al.. (1995). Retinoid X Receptor Acts as a Hormone Receptor in Vivo to Induce a Key Metabolic Enzyme for 1,25-Dihydroxyvitamin D3. Journal of Biological Chemistry. 270(41). 23906–23909. 41 indexed citations
10.
Howell, Stanley R., David Hicks, JoAnn Scatina, & Samuel F. Sisenwine. (1994). Pharmacokinetics of venlafaxine andO-desmethylvenlafaxine in laboratory animals. Xenobiotica. 24(4). 315–327. 38 indexed citations
11.
Howell, Stanley R., G. E. M. Husbands, JoAnn Scatina, & Samuel F. Sisenwine. (1993). Metabolic disposition of14C-venlafaxine in mouse, rat, dog, rhesus monkey and man. Xenobiotica. 23(4). 349–359. 102 indexed citations
12.
Howell, Stanley R., et al.. (1992). The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxine. Chirality. 4(2). 84–90. 51 indexed citations
13.
Howell, Stanley R. & Corné H. W. Klaassen. (1991). Circadian variation of hepatic UDP-glucuronic acid and the glucuronidation of xenobiotics in mice. Toxicology Letters. 57(1). 73–79. 9 indexed citations
14.
White, Catherine A., et al.. (1990). Effect of sulfhydryl-deficient diets on hepatic metallothionein, glutathione, and adenosine 3′-phosphate 5′-phosphosulfate (PAPS) levels in rats. Toxicology and Applied Pharmacology. 102(2). 259–267. 18 indexed citations
15.
Howell, Stanley R., et al.. (1988). 3-Hydroxylation of Salicylamide in Mice. Journal of Pharmaceutical Sciences. 77(4). 309–313. 1 indexed citations
16.
Gregus, Zoltán, Catherine A. White, Stanley R. Howell, & Curtis D. Klaassen. (1988). Effect of glutathione depletion on sulfate activation and sulfate ester formation in rats. Biochemical Pharmacology. 37(22). 4307–4312. 21 indexed citations
17.
Howell, Stanley R., et al.. (1987). Hepatic UDP-glucose and UDP-glucuronic acid synthesis rates in rats during a reduced energy state.. Drug Metabolism and Disposition. 15(3). 281–288. 7 indexed citations
18.
Howell, Stanley R., G A Hazelton, & Curtis D. Klaassen. (1986). Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated.. Journal of Pharmacology and Experimental Therapeutics. 236(3). 610–614. 31 indexed citations
19.
Howell, Stanley R., John E. Christian, & Gary E. Isom. (1986). The hepatotoxic potential of combined toluene-chronic ethanol exposure. Archives of Toxicology. 59(1). 45–50. 8 indexed citations
20.
Markoff, Edith, Stanley R. Howell, & Stuart Handwerger. (1983). Inhibition of Decidual Prolactin Release by a Decidual Peptide*. The Journal of Clinical Endocrinology & Metabolism. 57(6). 1282–1286. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026